Personalised cancer vaccine trials produce 'really hopeful' results The jab, made using similar technology to Oxford-AstraZeneca's COVID vaccine, sees DNA from an individual patient's tumour and cut and pasted into a harmless virus, which is injected into the body to train the immune system to be alert for cancer cells. Sky News
No comments:
Post a Comment